Palmetto宣布覆盖前列腺癌的安可待检测技术

  基因保健公司（Genomic Health）今日宣布国家医疗保险承包商Palmetto GBA发布了一项局部覆盖决定，批准公司的Oncotype DX检测技术用于对前列腺癌患者进行检测。
  早在今年早些时候Palmetto对于检测技术的局部覆盖决定（local coverage determination）就已经形成了决议，此后Oncotype DX用于前列腺癌的检测将遵循多种标准，包括仅能被Palmetto MolDX认证及培训注册程序的医师使用，而且使用医师必须监测受检患者的疾病进展，并且报告前列腺癌患者死亡及癌症转移情况。
  Oncotype DX用于进行前列腺癌的检测技术将对肿瘤的恶化程度进行基因组的评估，用于帮助医生们决定哪一类患者的风险足够低，以便可以对患者进行更好地管理来避免昂贵的医疗干预花费。
  基因保健公司的CEO Kim Popovits表示，有了医疗保险的覆盖，每年将近有6万名前列腺癌患者及医生们都将会有机会通过Oncotype DX基因组前列腺癌评分信息，来进行最佳的疗法决策过程；局部覆盖决定的有效日期范围将在正式通知后的45天开始有效，该公司表示。（转化医学网360zhyx.com）
  以上为转化医学网原创翻译整理，转载请注明出处和链接！
转化医学网推荐的新闻阅读：
Palmetto Finalizes LCD for Genomic Health's Oncotype DX Prostate Cancer Test

Genomic Health announced today that national Medicare contractor Palmetto GBA has issued a favorable final local coverage determination approving coverage of the company's Oncotype DX prostate cancer test for qualified patients.

The decision by Palmetto finalizes the draft LCD issued by the contractor earlier this year, under which coverage for Oncotype DX prostate is subject to several criteria, including that testing may only be performed by physicians enrolled in a Palmetto MolDX-approved Certification and Training Registry program, and that physicians must monitor tested patients for disease progression and report any cases of metastasis or prostate cancer deaths in patients who were deemed low risk by the assay.

Oncotype DX prostate provides a genomic assessment of a tumor's aggressiveness in order to help doctors decide which patients are at low enough risk that they can be more conservatively managed, avoiding costly medical interventions.

"With Medicare's coverage, each year, nearly 60,000 prostate cancer patients and their physicians will now have the opportunity to make more optimal treatment decisions based on the unique biological information revealed by the Oncotype DX Genomic Prostate Score," Genomic Health President and CEO Kim Popovits said in a statemet.

The effective date for coverage under the newly final LCD will begin after a 45-day notice period, the company said.